GIA
PBYI icon

GHP Investment Advisors’s Puma Biotechnology PBYI Stock Holding History

GHP Investment Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.49K Hold
1,170
– – ﹤0.01% 819
2026
Q1 		$7.48K Hold
1,170
– – ﹤0.01% 848
2025
Q4 		$6.96K Hold
1,170
– – ﹤0.01% 780
2025
Q3 		$6.21K Hold
1,170
– – ﹤0.01% 760
2025
Q2 		$4.01K Hold
1,170
– – ﹤0.01% 816
2025
Q1 		$3.46K Hold
1,170
– – ﹤0.01% 817
2024
Q4 		$3.57K Hold
1,170
– – ﹤0.01% 848
2024
Q3 		$2.98K Hold
1,170
– – ﹤0.01% 863
2024
Q2 		$3.81K Hold
1,170
– – ﹤0.01% 801
2024
Q1 		$6.2K Hold
1,170
– – ﹤0.01% 697
2023
Q4 		$5.07K Hold
1,170
– – ﹤0.01% 708
2023
Q3 		$2.76K Hold
1,170
– – ﹤0.01% 825
2023
Q2 		$4.53K Hold
1,170
– – ﹤0.01% 779
2023
Q1 		$3.62K Hold
1,170
– – ﹤0.01% 800
2022
Q4 		$4.95K Hold
1,170
– – ﹤0.01% 785
2022
Q3 		$3K Hold
1,170
– – ﹤0.01% 812
2022
Q2 		$3K Hold
1,170
– – ﹤0.01% 831
2022
Q1 		$3K Buy
+1,170
New +$3.03K ﹤0.01% 863

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GHP Investment Advisors's PBYI Position: Q2 2026 in Review

GHP Investment Advisors held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 1,170 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

GHP Investment Advisors first reported a position in PBYI in Q1 2022 and has held it in 18 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • GHP Investment Advisors held 1,170 shares of Puma Biotechnology worth $9.49K as of Q2 2026.
  • GHP Investment Advisors left its Puma Biotechnology share count unchanged in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #819 holding.
  • GHP Investment Advisors first reported a position in Puma Biotechnology in Q1 2022 and has held it in 18 quarters since.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.